Curist Mucus Relief

Manufacturer
Little Pharma, Inc.
Effective date
2022-07-25
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 21:55:57

Label at a glance#

ProductCurist Mucus Relief
Active ingredientGUAIFENESIN
Label structure16 sections

Storage and handling

Other information tamper evident: do not use if carton is open or if printed seal on blister is broken or missing store between 20 to 25°C (68 to 77°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each extended release tablet)

Guaifenesin 600 mg

OTC - PURPOSE SECTION

Purpose

Expectorant

INDICATIONS & USAGE SECTION

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

WARNINGS SECTION

Warnings

OTC - DO NOT USE SECTION

Do not use

  • for children under 12 years of age

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

DOSAGE & ADMINISTRATION SECTION

Directions

  • do not crush, chew, or break tablet
  • take with a full glass of water
  • this product can be administered without regard for the timing of meals
  • adults and children 12 years of age and over: 1 or 2 tablets every 12 hours. Do not exceed 4 tablets in 24 hours.
  • children under 12 years of age: do not use

STORAGE AND HANDLING SECTION

Other information

  • tamper evident: do not use if carton is open or if printed seal on blister is broken or missing
  • store between 20 to 25°C (68 to 77°F)

INACTIVE INGREDIENT SECTION

Inactive ingredients carbomer homopolymer, hypromellose, microcrystalline cellulose, povidone

OTC - QUESTIONS SECTION

Questions? 1-844-243-1241

You may also report side effects to this phone number.

SPL UNCLASSIFIED SECTION

Distributed by:

Little Pharma, Inc.

New York, NY 10023

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

curist

Mucus Relief

Guaifenesin Extended-Release Tablets 600 mg

Expectorant

12 Hour

Relieves Chest Congestion

Thins and Loosens Mucus

30 Extended Release Tablets

Mucus ReliefMucus Relief

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72559-00172559-001-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209215-001GUAIFENESINGUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06
A209215-002GUAIFENESINGUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-0684e616aacf4f…
2026-09-14 22:38:342026-08A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-0684e616aacf4f…
2026-08-18 06:07:402026-07A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06caaa826d4ba7…
2026-08-18 06:07:402026-07A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-0631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-0631067a03dcf5…
2025-08-23 18:47 UTC2025-08A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-066a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-066a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-0603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-0603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-062680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-062680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-065bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-065bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06d06236e962d9…
2024-10-29 15:01 UTC2024-10A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-0679d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-0679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-06301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-06301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-061e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-061e350fbaab3a…
2024-05-31 18:47 UTC2024-05A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-068072bd15b7f6…
2024-05-31 18:47 UTC2024-05A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-068072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-065c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-065c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-065d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-065d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-064b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-064b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A209215-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2017-09-0674a2ff9319b5…
2019-12-13 00:20 UTC2019-12A209215-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2017-09-0674a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2632024f-920c-feb0-e063-6394a90ade998a9b9230-ed87-7a61-e053-2995a90a33ac2024-11-05WarningsExact identifier
spl set id: 8a9b9230-ed87-7a61-e053-2995a90a33ac

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.